UA125700U - ANTIARITHMIC MEANS TO REDUCE MAGNESIUM AND POTASSIUM DEFICIENCY IN THE TABLE - Google Patents
ANTIARITHMIC MEANS TO REDUCE MAGNESIUM AND POTASSIUM DEFICIENCY IN THE TABLEInfo
- Publication number
- UA125700U UA125700U UAU201711412U UAU201711412U UA125700U UA 125700 U UA125700 U UA 125700U UA U201711412 U UAU201711412 U UA U201711412U UA U201711412 U UAU201711412 U UA U201711412U UA 125700 U UA125700 U UA 125700U
- Authority
- UA
- Ukraine
- Prior art keywords
- asparaginate
- magnesium
- potassium
- antiarithmic
- potassium deficiency
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Фармацевтична композиція для орального застосування у формі антиаритмічного лікарського засобу, що усуває дефіцит магнію і калію, включає як активні компоненти комбінацію магнію аспарагінату тетрагідрату та калію аспарагінату напівгідрату, а також фармацевтично прийнятні допоміжні речовини для забезпечення стабільності, при наступному співвідношенні інгредієнтів (% мас.): активні фармацевтичні компоненти:магнію аспарагінату тетрагідрат33,25-36,75калію аспарагінату напівгідрат33,25-36,75допоміжні речовини:зв'язуюча речовина0,25-5,0солюбілізатор або дезінтегрант1,0-5,0лубрикант та речовина, що сприяє ковзанню0,5-3,0наповнювачрешта.A pharmaceutical composition for oral administration in the form of an antiarrhythmic drug that eliminates magnesium deficiency and potassium includes, as active ingredients, a combination of magnesium asparaginate tetrahydrate and potassium asparaginate hemihydrate, as well as pharmaceutically acceptable auxiliaries for stability, in the following proportions. : active pharmaceutical components: magnesium asparaginate tetrahydrate33,25-36,75 potassium asparaginate hemihydrate33,25-36,75 auxiliary substances: binder0,25-5,0 solubilization op or dezintehrant1,0-5,0lubrykant and a substance that promotes kovzannyu0,5-3,0napovnyuvachreshta.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201711412U UA125700U (en) | 2017-11-21 | 2017-11-21 | ANTIARITHMIC MEANS TO REDUCE MAGNESIUM AND POTASSIUM DEFICIENCY IN THE TABLE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201711412U UA125700U (en) | 2017-11-21 | 2017-11-21 | ANTIARITHMIC MEANS TO REDUCE MAGNESIUM AND POTASSIUM DEFICIENCY IN THE TABLE |
Publications (1)
Publication Number | Publication Date |
---|---|
UA125700U true UA125700U (en) | 2018-05-25 |
Family
ID=62171199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201711412U UA125700U (en) | 2017-11-21 | 2017-11-21 | ANTIARITHMIC MEANS TO REDUCE MAGNESIUM AND POTASSIUM DEFICIENCY IN THE TABLE |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA125700U (en) |
-
2017
- 2017-11-21 UA UAU201711412U patent/UA125700U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20210401A1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM | |
CL2017003209A1 (en) | Orodispersible dosing unit containing an estetrol component | |
CL2017003208A1 (en) | Orodispersible dosing unit containing an estetrol component | |
TW200837074A (en) | Extended triterpene derivatives | |
CY1124914T1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING AN INTEGRATION INHIBITOR | |
EP2588116A4 (en) | Posaconazole intravenous solution formulations stabilized by substituted beta-cyclodextrin | |
EA201992116A1 (en) | PHARMACEUTICAL COMPOSITIONS OF FLOROGLUCINOL AND TRIMETHYLFLOROGLUCINOL | |
FR2878161B1 (en) | ORAL MEDICINE FORM, SOLID AND DESIGNED TO AVOID MEASUREMENT | |
MX2021006969A (en) | Peptide binder. | |
EA202190115A1 (en) | FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS FOR THEIR PREPARATION | |
EA201490222A1 (en) | COMBINED COMPOSITIONS BASED ON DARUNAVIR | |
PE20211588A1 (en) | COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS ASSOCIATED WITH MENOPAUSE | |
MX2020007760A (en) | Compositions and methods of enhancing 5-hydroxytryptophan bioavailability. | |
CL2019003533A1 (en) | Use of vibegron to treat overactive bladder. | |
MX2017013636A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from different particles. | |
MX2022006940A (en) | Pharmaceutical compositions comprising cabotegravir. | |
MX2017005163A (en) | Onapristone extended-release compositions and methods. | |
UA125700U (en) | ANTIARITHMIC MEANS TO REDUCE MAGNESIUM AND POTASSIUM DEFICIENCY IN THE TABLE | |
MX2017013633A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from particles. | |
RU2013124416A (en) | DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | |
MX2018005345A (en) | Pharmaceutical compositions of dimethyl fumarate. | |
MX2017013643A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix. | |
NZ769842A (en) | Triterpene amine derivatives | |
AR067320A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS | |
UA123399U (en) | PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE |